Nadia Khan, MD

Nadia Khan MD, is the Director of the CLL Division at the Center for Blood Disorders and Cellular Therapy at Swedish Cancer Insitute in Seattle. She is committed to the implementation and development of clinical trials utilizing novel targeted agents in the management of CLL and lymphomas. Dr. Khan served on the NCCN committee panels for lymphoma and CLL, prior to her appointment at Swedish.

Financial relationships

Attribution:
Self
Type of financial relationship:
Independent contractor
Ineligible company:
Adaptive
Topic:
Cell Free DNA
Date added:
05/05/2023
Relationship end date:
12/22/2022
Attribution:
Self
Type of financial relationship:
Independent contractor
Ineligible company:
Beigene
Topic:
CLL
Date added:
05/05/2023
Relationship end date:
11/22/2022
Attribution:
Self
Type of financial relationship:
Independent contractor
Ineligible company:
PCYC
Date added:
05/05/2023
Relationship end date:
05/08/2024

Return to Seattle Cellular Therapy Summit: Patient-Centered Approach to Improve Outcomes

Premier Hematology Oncology Conferences

Bookmark/Search this post

Nadia Khan, MD

Financial relationships

3380 146th PL SE, Suite 330	Bellevue, WA 98007	Phone - 425-6 16-0572
Visit our website to learn about our Global projects	Binaytara Foundation Cancer Center in Nepal

You are here

Nadia Khan, MD

Financial relationships